Navigation Links
ORF Genetics Opens Revolutionary 'Green Factory' in Iceland

Human growth factors produced in barley grain, using renewable, geothermal energy

REYKJAVIK, Iceland, May 13 /PRNewswire-USNewswire/ -- ORF Genetics (, an Icelandic biotechnology company, announced today the opening of new and revolutionary 22,000 ft^2 (2043m^2) cultivation facilities in Grindavik, Iceland. Utilizing its unique Orfeus(TM) protein production system in barley, ORF Genetics produces and markets biorisk-free ISOkine(TM) human growth factors for use in medical research, drug discovery and cosmetics.

(Photo: )

The state-of-the-art Green Factory uses geothermal energy for safe, indoor cultivation of genetically engineered barley. It is set in the middle of a lava field, close to Icelands best-known tourist attraction, the Blue Lagoon. The barley is cultivated in a soil-less hydroponic system on specially designed conveyor belts, allowing for the production of up to 90 different proteins at a time. The Orfeus(TM) system and new facilities allow ORF the flexibility to easily scale their production according to the unique requirements of different customers and markets. Currently ORF has more than 100 different growth factors in its pipeline and 10 ISOkine(TM) growth factors already on the market.

Bjorn L. Orvar, CEO of ORF Genetics, said at the opening of the greenhouse: "Our research and development efforts in recent years are now bearing fruit, and we see great opportunities for rapid growth, specifically in the field of drug discovery and cosmetics."

Minister of Industry Ossur Skarphedinsson said as he harvested the first barley in the Green Factory: "ORF's ideas have sprouted from the dynamic Icelandic public research environment, and the company's leaders, with unflagging entrepreneurial optimism, have overcome all difficulties, making ORF a unique high-tech company in the world. The new 'Green Factory' leverages the company's deserved green image, as production is based on green and renewable energy from Iceland's volcanic depths."

ORF will be exhibiting their products in the US at the upcoming Supplier's Day Show hosted by the New York Society for Cosmetic Chemists in May.

ORF Genetics

Headquartered in Reykjavik, Iceland, ORF Genetics Ltd. is a privately owned biotech company that is committed to economically viable green technology for the production of growth factors and other hard-to-produce recombinant proteins. Utilizing its unique Orfeus(TM) plant-based expression system, the company is currently producing biorisk-free, high purity ISOkine(TM) products to serve the needs of the medical research, cell culture media, diagnostics and cosmetic markets. ORF was recently awarded the prestigious 2008 Icelandic Innovation Award by the Icelandic Centre for Research and the Icelandic Trade Council.

Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
2. Response Genetics Reports Second Quarter 2007 Financial Results
3. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
4. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
5. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
6. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
7. Interleukin Genetics Announces Management and Board Appointments
8. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
9. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
10. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
11. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna ... announced today that the remaining 11,000 post-share consolidation ... Purchase Warrants (the "Series B Warrants") subject to ... exercised on November 23, 2015, which will result ... After giving effect to the issuance of such ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... are paramount. Insertion points for in-line sensors can represent a weak spot where ... InTrac 781/784 series of retractable sensor housings , which are designed to tolerate ...
(Date:11/24/2015)... Vancouver, BC (PRWEB) , ... November 24, 2015 ... ... to our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology ... Creation Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device ...
(Date:11/24/2015)... 24, 2015 Capricor Therapeutics, Inc. ... the discovery, development and commercialization of first-in-class therapeutics, today ... Officer, is scheduled to present at the 2015 Piper ... a.m. EST, at The Lotte New York Palace Hotel ... . --> . ...
Breaking Biology Technology:
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
(Date:10/29/2015)... 2015   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that it has ... as one of only three finalists for a ... and Growing" category. The Tekne Awards honor Minnesota ... technology innovation and leadership. iMedNet™ eClinical ...
Breaking Biology News(10 mins):